Ditchcarbon
  • Contact
  1. Organizations
  2. United Therapeutics
Public Profile
Pharmaceutical Preparation Manufacturing
US
updated a month ago

United Therapeutics

Company website

United Therapeutics Corporation, commonly referred to as United Therapeutics, is a pioneering biotechnology company headquartered in the United States. Founded in 1996, the company has established itself as a leader in the development of innovative therapies for patients with chronic and life-threatening conditions, particularly in the field of pulmonary arterial hypertension (PAH). With a strong operational presence across North America and Europe, United Therapeutics focuses on creating unique, life-saving products, including its flagship medications like Remodulin and Tyvaso. These therapies are distinguished by their advanced delivery systems and commitment to improving patient quality of life. Recognised for its significant contributions to the biopharmaceutical industry, United Therapeutics has achieved notable milestones, including the successful development of organ preservation technologies. The company continues to solidify its market position through ongoing research and a dedication to addressing unmet medical needs.

DitchCarbon Score

How does United Therapeutics's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.

25

Industry Average

Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.

31

Industry Benchmark

United Therapeutics's score of 25 is lower than 54% of the industry. This can give you a sense of how well the company is doing compared to its peers.

46%

Let us know if this data was useful to you

United Therapeutics's reported carbon emissions

United Therapeutics, headquartered in the US, currently does not have available carbon emissions data for the most recent year, nor does it report specific reduction targets or initiatives. The company has not disclosed any emissions figures, including Scope 1, 2, or 3 emissions, nor has it outlined any commitments to climate pledges or science-based targets (SBTi). As a result, there is no quantifiable information regarding their carbon footprint or climate action strategies at this time. The absence of data suggests that United Therapeutics may still be in the early stages of developing comprehensive climate commitments or reporting frameworks.

Industry emissions intensity

Very low
Low
Medium
High
Very high
Some industries are more carbon intensive than others. United Therapeutics's primary industry is Pharmaceutical Preparation Manufacturing, which is very low in terms of carbon intensity compared to other industries.

Location emissions intensity

Very low
Low
Medium
High
Very high
The carbon intensity of the energy grid powering a company's primary operations has a strong influence on its overall carbon footprint. This request for United Therapeutics is in US, which has a low grid carbon intensity relative to other regions.

Reduction initiatives & disclosure networks

Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.

United Therapeutics is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.

Science Based Targets Initiative
Carbon Disclosure Project
The Climate Pledge
UN Global Compact
RE 100
Climate Action 100
Race To Net Zero
Reduction Actions

Similar Organizations

Eli Lilly and Company

GB
•
Pharmaceutical Preparation Manufacturing
Updated about 6 hours ago

Glaxosmithkline

GB
•
Pharmaceutical Preparation Manufacturing
Updated about 13 hours ago

Astra Zeneca

GB
•
Pharmaceutical Preparation Manufacturing
Updated 5 days ago

Actelion Ltd

CH
•
Pharmaceutical Preparation Manufacturing
Updated 13 days ago

Gilead Sciences

US
•
Pharmaceutical Preparation Manufacturing
Updated 4 days ago

Pfizer

US
•
Pharmaceutical Preparation Manufacturing
Updated 13 days ago

Where does DitchCarbon data come from?

Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers

Ditchcarbon
v251007.2
[email protected]+44 203 475 7875Ditch Carbon Ltd167-169 Great Portland StreetLondon W1W 5PF
UL Solutions verification badge
CDP logo
Gartner Cool Vendor 2025 badge
ProductPortalScope 3 Tool FunctionalityDataIntegrationsPricing
CustomersHaleonGrant ThorntonHikmaRead all stories
SolutionsProcurement teamsSustainability teamsPlatform ownersCarbon accountants
ResourcesCalculation MethodologyDocumentationBlogFAQOrganizationsIndustriesSBTI APITrust CentreChangelog
AboutTeamCareersLicense AgreementPrivacy